IP Verse

Flavivirus Vaccines - EP3679915

The patent EP3679915 was granted to Sanofi Pasteur on Jun 1, 2022. The application was originally filed on Jan 15, 2003 under application number EP20159597A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3679915

SANOFI PASTEUR
Application Number
EP20159597A
Filing Date
Jan 15, 2003
Status
Granted And Under Opposition
Apr 29, 2022
Grant Date
Jun 1, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TAKEDAJan 20, 2023MAIWALDWITHDRAWN

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS19650603485-
DESCRIPTIONWO2000US32821-
DESCRIPTIONUS5173418
OPPOSITIONUS7641907
OPPOSITIONWO0139802
OPPOSITIONWO0160847
OPPOSITIONWO03103571
OPPOSITIONWO9837911
SEARCHWO0139802

Non-Patent Literature (NPL) Citations (37) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BRAY et al., Proc. Natl. Acad. Sci. U.S.A., (19910000), vol. 88, pages 10342 - 10346-
DESCRIPTION- BURKE et al., Am. J. Trop. Med. Hyg., (19880000), vol. 38, pages 172 - 180-
DESCRIPTION- CECILIA et al., Virology, (19910000), vol. 181, pages 70 - 77-
DESCRIPTION- CHAMBERS et al., J. Virol., (19990000), vol. 73, pages 3095 - 3101-
DESCRIPTION- CHAMBERS et al., J. ViroL, (19990000), vol. 73, pages 3095 - 3101-
DESCRIPTION- "Dengue and Dengue Hemorrhagic Fever", HALSTEAD, CABI Publ., New York, (19970000), pages 23 - 44-
DESCRIPTION- "Flaviviridae", RICE, Virology, Raven-Lippincott, (19950000), page 937-
DESCRIPTION- "GeneBank", Database accession no. D90195-
DESCRIPTION- GUIRAKHOO et al., J. Virol., (20010000), vol. 75, pages 7290 - 7304-
DESCRIPTION- LEVENBOOK et al., J. Biol. Stand., (19870000), vol. 15, pages 305 - 313-
DESCRIPTION- MONATH et al., Curr. Drugs Infect Dis., (20010000), vol. 1, pages 37 - 50-
DESCRIPTION- MONATH et al., Curr. Drugs- Infect Dis., (20010000), vol. 1, pages 37 - 50-
DESCRIPTION- MONATH et al., J. Virol., (20000000), vol. 74, pages 1742 - 1751-
DESCRIPTION- MONATH et al., Vaccine, (19990000), vol. 17, pages 1869 - 1882-
DESCRIPTION- MORRIS-DOWNES et al., Vaccine, (20010000), vol. 19, pages 3877 - 3884-
DESCRIPTION- REED et al., Am. J. Hyg., (19380000), vol. 27, pages 493 - 497-
DESCRIPTION- REY et al., Nature, (19950000), vol. 375, pages 291 - 298-
DESCRIPTION- SUMIYOSHI et al., Virology, (19870000), vol. 161, pages 497 - 510-
DESCRIPTION- "The Virus", THEILER, Yellow Fever, McGraw Hill, (19510000), pages 46 - 136-
DESCRIPTION- "Tick-bome Encephalitis", GRESIKOVA et al., The Arboviruses, Ecology and Epidemiology, CRC Press, (19880000), pages 177 - 203-
DESCRIPTION- WANG et al., J. Gen. Virol., (19950000), vol. 76, pages 2749 - 2755-
DESCRIPTION- XIONG et al., Science, (19910000), vol. 243, pages 1188 - 1191-
DESCRIPTION- YASUMURA et al., Nihon Rinsho, (19630000), vol. 21, pages 1201 - 1215-
DESCRIPTION- "Yellow Fever", MONATH, Plotldn and Orenstein, (19990000), pages 815 - 879-
OPPOSITION- Burke Donald S, "Chapter 33 Flaviruses", Fields Virology volume 1, (20010101), pages 1043 - 1045, XP093033771-
OPPOSITION- T. CHAMBERS ET AL., "Yellow fever/japanese encephalitis chimeric viruses: construction and biological properties", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19990101), vol. 73, no. 4, ISSN 0022-538X, pages 3095 - 3101, XP002139409-
OPPOSITION- HUANG C. Y.-H. ET AL., "Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (20000401), vol. 74, no. 7, doi:10.1128/JVI.74.7.3020-3028.2000, ISSN 0022-538X, pages 3020 - 3028, XP002174039
OPPOSITION- GUIRAKHOO F, ET AL, "CONSTRUCTION,SAFETY,AND IMMUNOGENICITY IN NONHUMAN PRIMATES OF A CHIMERIC YELLOW FEVER-DENGUE VIRUS TETRAVALENT VACCINE", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (20010801), vol. 75, no. 10, doi:10.1128/JVI.75.16.7290-7304.2001, ISSN 0022-538X, pages 7290 - 7304, XP002961663
OPPOSITION- PUGACHEV KONSTANTIN V ET AL, "High fidelity of yellow fever virus RNA polymerase.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (20040101), vol. 78, no. 2, doi:10.1128/JVI.78.2.1032-1038.2004, ISSN 0022-538X, pages 1032 - 1038, XP002438441
SEARCH- BRAY MICHAEL ET AL, "Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence", JOURNAL OF VIROLOGY, (199802), vol. 72, no. 2, ISSN 0022-538X, pages 1647 - 1651, XP002313125 [I] 1-15 * the whole document *-
SEARCH- CHEN LI-KUANG ET AL, "Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro", VIROLOGY, (1996), vol. 223, no. 1, ISSN 0042-6822, pages 79 - 88, XP002313126 [A] 1-15 * the whole document *
SEARCH- LEE E ET AL, "Changes in the Dengue Virus Major Envelope Protein on Passaging and Their Localization on the Three-Dimensional Structure of the Protein", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, (19970609), vol. 232, no. 2, ISSN 0042-6822, pages 281 - 290, XP004452235 [I] 1-15 * the whole document *
SEARCH- DOS SANTOS CLAUDIA NUNES DUARTE ET AL, "Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus", VIROLOGY, (20000901), vol. 274, no. 2, ISSN 0042-6822, pages 292 - 308, XP004435931 [I] 1-15 * the whole document *
SEARCH- GUIRAKHOO F ET AL, "CONSTRUCTION,SAFETY,AND IMMUNOGENICITY IN NONHUMAN PRIMATES OF A CHIMERIC YELLOW FEVER-DENGUE VIRUS TETRAVALENT VACCINE", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20010801), vol. 75, no. 10, doi:10.1128/JVI.75.16.7290-7304.2001, ISSN 0022-538X, pages 7290 - 7304, XP002961663 [AD] 1-15 * abstract *
SEARCH- ARROYO J ET AL, "Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (chimerivax-je)", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (200101), vol. 75, no. 2, ISSN 0022-538X, pages 934 - 942, XP002967301 [A] 1-15 * the whole document *
SEARCH- MONATH THOMAS P ET AL, "Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: Relevance to development and safety testing of live, attenuated vaccines", JOURNAL OF VIROLOGY, (200202), vol. 76, no. 4, ISSN 0022-538X, pages 1932 - 1943, XP002313127 [AP] 1-15 * the whole document *
SEARCH- GUIRAKHOO F ET AL, "A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.", JOURNAL OF VIROLOGY. SEP 2004, (200409), vol. 78, no. 18, ISSN 0022-538X, pages 9998 - 10008, XP009042435 [T] 1-15

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents